ANTONIO MANCINI D.O. NPI 1629091251

NPI Details

Antonio Mancini, D.O. is an urology in Orland Park, IL with 25 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. Antonio Mancini, D.O. NPI is 1629091251. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

15234 S HARLEM AVE
ORLAND PARK, IL
ZIP 60462-330
Phone: (708) 888-8287
Fax: (708) 614-0607

The NPI 1629091251 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Bcg live intravesical instillation, 1 mg (HCPCS:J9030)
• Automated urinalysis test (HCPCS:81003)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Complex measurement of pressure of urine flow in bladder with voiding pressure studies (HCPCS:51728)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings (HCPCS:51784)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Insertion of implant in urethra within prostate gland using an endoscope, each additional implant (HCPCS:52442)
• Injection, amikacin sulfate, 100 mg (HCPCS:J0278)
• Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique (HCPCS:87496)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for herpes simplex virus, amplified probe technique (HCPCS:87529)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Cell examination of urine, manual (HCPCS:88120)
• Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Simple insertion of temporary bladder tube (HCPCS:51702)
• Insertion of device into abdomen with pressure and urine flow rate study (HCPCS:51797)
• Special stained specimen slides to examine tissue, each multiplex procedure (HCPCS:88344)
• Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method (HCPCS:G0416)
• Biopsy of prostate gland (HCPCS:55700)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
• Shock wave crushing of kidney stones (HCPCS:50590)
• Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm (HCPCS:52224)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Insertion of implant in urethra within prostate gland using an endoscope, 1 implant (HCPCS:52441)
• Complete laser vaporization of prostate including control of bleeding using an endoscope (HCPCS:52648)
• Cell examination of specimen, concentration technique (HCPCS:88108)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 7/25/2006 and was last updated on 4/16/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.